Epidemiology and risk factors for mortality in clostridial bacteremia in Japan: A retrospective multicenter observational study

被引:0
作者
Okazaki, Aiko [1 ]
Okugawa, Shu [1 ]
Kobayashi, Tatsuya [2 ]
Kawada, Miki [2 ]
Kawase, Kyotaro [3 ]
Nakayama, Shin [3 ]
Wakabayashi, Yoshitaka [3 ]
Kitazawa, Takatoshi [3 ]
Takezawa, Riko [4 ]
Tatsuno, Keita [4 ]
Koyano, Saho [5 ]
Higurashi, Yoshimi [5 ]
Ikeda, Mahoko [1 ]
Harada, Sohei [5 ]
Tsutsumi, Takeya [1 ,5 ]
机构
[1] Univ Tokyo Hosp, Dept Infect Dis, 7-3-1 Hongo,Bunkyo, Tokyo 1138655, Japan
[2] Saitama City Hosp, Dept Infect Dis, Saitama, Japan
[3] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo, Japan
[4] Mitsui Mem Hosp, Dept Infect Control & Prevent, Tokyo, Japan
[5] Univ Tokyo Hosp, Dept Infect Control & Prevent, Tokyo, Japan
关键词
Clostridium; Bacteremia; Mortality; Epidemiology; PERFRINGENS BACTEREMIA; CLINICAL-SIGNIFICANCE; GUIDELINES; FEATURES; OUTCOMES; THERAPY;
D O I
10.1016/j.ijid.2024.107358
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Clostridium species are ubiquitous in nature and commonly cause infections, including bacteremia. C. perfringens is often the causative species, while the epidemiology of other clostridial species remains unclear. This study aimed to examine the epidemiology and risk factors for mortality among patients with clostridial bacteremia in Japan. Methods: This multicenter, retrospective cohort study analyzed patients with Clostridium spp. in blood cultures from four tertiary hospitals in Japan. Data on demographics, underlying conditions, clinical and laboratory values, and in-hospital mortality were included. Multivariate logistic regression analysis identified independent risk factors for in-hospital mortality. Results: Of 349 patients with Clostridium spp. in blood cultures, 278 (79.7%) had clinically significant clostridial bacteremia: C. perfringens was the most common species (52.9%), followed by C. ramosum (9.7%) and C. clostridioforme (4.3%). The median patient age was 77 years, and 61.9% were male. The in-hospital mortality rate was 25.9%, with 34.7% of deaths occurring within 3 days of the date of the positive blood culture. Independent risk factors for mortality were hepato-pancreato-biliary malignancy, chronic heart failure, acute renal failure, Pitt bacteremia score, and pneumonia. Conclusions: Mortality from clostridial bacteremia is high, particularly among patients with pneumonia, comorbidities, or severe acute conditions. To improve mortality, early-stage treatment strategies are needed. (c) 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
引用
收藏
页数:7
相关论文
共 30 条
  • [1] Clostridiumbacteremia and its implications: A case report
    Bonda, Sruthi
    Lee, Kevin
    Rovig, John
    Asad, Shadaba
    [J]. IDCASES, 2022, 29
  • [2] Anaerobic bacteraemia: A score predicting mortality
    Cobo, Fernando
    Aliaga, Luis
    Exposito-Ruiz, Manuela
    Maria Navarro-Mari, Jose
    [J]. ANAEROBE, 2020, 64
  • [3] Anaerobic bacteraemia: a 10-year retrospective epidemiological survey
    De Keukeleire, Steven
    Wybo, Ingrid
    Naessens, Anne
    Echahidi, Fedoua
    Van der Beken, Mieke
    Vandoorslaer, Kristof
    Vermeulen, Stefan
    Pierard, Denis
    [J]. ANAEROBE, 2016, 39 : 54 - 59
  • [4] Epidemiology and microbiological features of anaerobic bacteremia in two French University hospitals
    Dumont, Yann
    Bonzon, Lucas
    Michon, Anne-Laure
    Carriere, Christian
    Didelot, Marie-Noelle
    Laurens, Chrislene
    Renard, Beatrice
    Veloo, Alida C. M.
    Godreuil, Sylvain
    Jean-Pierre, Helene
    [J]. ANAEROBE, 2020, 64
  • [5] Clinical and Epidemiological Features of Clostridium perfringens Bacteremia: A Review of 18 Cases over 8 Year-Period in a Tertiary Care Center in Metropolitan Tokyo Area in Japan
    Fujita, Hiroshi
    Nishimura, Shigeko
    Kurosawa, Saiko
    Akiya, Itsuo
    Nakamura-Uchiyama, Fukumi
    Ohnishi, Kenji
    [J]. INTERNAL MEDICINE, 2010, 49 (22) : 2433 - 2437
  • [6] Gilbert DN., 2023, The Sanford Guide to Antimicrobial Therapy 2023, V53
  • [7] Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis
    Gomi, Harumi
    Solomkin, Joseph S.
    Schlossberg, David
    Okamoto, Kohji
    Takada, Tadahiro
    Strasberg, Steven M.
    Ukai, Tomohiko
    Endo, Itaru
    Iwashita, Yukio
    Hibi, Taizo
    Pitt, Henry A.
    Matsunaga, Naohisa
    Takamori, Yoriyuki
    Umezawa, Akiko
    Asai, Koji
    Suzuki, Kenji
    Han, Ho-Seong
    Hwang, Tsann-Long
    Mori, Yasuhisa
    Yoon, Yoo-Seok
    Huang, Wayne Shih-Wei
    Belli, Giulio
    Dervenis, Christos
    Yokoe, Masamichi
    Kiriyama, Seiki
    Itoi, Takao
    Jagannath, Palepu
    Garden, O. James
    Miura, Fumihiko
    de Santibanes, Eduardo
    Shikata, Satoru
    Noguchi, Yoshinori
    Wada, Keita
    Honda, Goro
    Supe, Avinash Nivritti
    Yoshida, Masahiro
    Mayumi, Toshihiko
    Gouma, Dirk J.
    Deziel, Daniel J.
    Liau, Kui-Hin
    Chen, Miin-Fu
    Liu, Keng-Hao
    Su, Cheng-Hsi
    Chan, Angus C. W.
    Yoon, Dong-Sup
    Choi, In-Seok
    Jonas, Eduard
    Chen, Xiao-Ping
    Fan, Sheung Tat
    Ker, Chen-Guo
    [J]. JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2018, 25 (01) : 3 - 16
  • [8] Haddy RI, 2000, SCAND J INFECT DIS, V32, P27, DOI 10.1080/00365540050164173
  • [9] TOXIGENIC CLOSTRIDIA
    HATHEWAY, CL
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1990, 3 (01) : 66 - 98
  • [10] HILF M, 1989, AM J MED, V87, P540, DOI 10.1016/S0002-9343(89)80611-4